Year 2023 Vol. 31 No 1

SCIENTIFIC PUBLICATIONS

O.A. KUDELICH 1, G.G. KANDRATSENCA 1, M.P. POTAPNEV 2

APPLICATION OF PLATELET-RICH PLASMA IN SEVERE ACUTE EXPERIMENTAL PANCREATITIS

Belarusian State Medical University 1,
Republican Research & Production Center for Transfusiology & Medical Biotechnologies 2, Minsk,
Republic of Belarus

Objective. To determine the effect of regional application of platelet-rich plasma on the systemic manifestations of severe acute experimental pancreatitis in rats.
Methods. This experimental study was carried out on 42 adults Wistar rats. Acute experimental pancreatitis (AEP) was induced by the introduction of a 0.3 ml of 5% solution of nonionic polyethylene glycol octylphenol ether detergent into the caudal part of the pancreas. The animals were randomly divided into 4 groups: Group I (n=6) - intact animals, Group II (control group) (n=12) – rats with AEP without treatment, Group III (n=12) - rats with AEP treated: anesthesia + infusions of 0.9% sodium chloride solution (saline), Group IV (n=12) - rats with AEP treated: anesthesia + infusions of saline + regional application of platelet-rich plasma (PRP). Animals were taken out of the experiment by euthanasia on the 3rd and 7th day. The hematological parameters, markers of systemic manifestation of the pathological process (pancreatic amylase, ASAT, ALAT, urea, creatinine), markers of endogenous intoxication (lipid peroxidation activity, nitric oxide level), markers of systemic inflammatory response (C-reactive protein, tumor necrosis factor-alpha, interleukin-6) have been evaluated.
Results. The application of PRP in the early stages of severe AEP favorably affects the change of the number and size of platelets, helps to reduce the content of free radical oxidation products, enzymes and endogenous intoxication elements, which are key links in the pathogenesis of severe acute pancreatitis. The cytoprotective effect of using PRP in the early stages of AEP on the prevention of cytolysis of hepatic and other body cells was revealed.
Conclusion. Experimental studies have revealed the ability of regional application of PRP in the early stages of AEP in rats to have a systemic positive effect, which allows considering it as a promising agent for pathogenetic treatment.

Keywords: severe acute pancreatitis, plasma, soluble platelet factors, cell therapy, PRP, biological product
p. 5-15 of the original issue
References
  1. Singh P, Garg PK. Pathophysiological mechanisms in acute pancreatitis: Current understanding. Indian J Gastroenterol. 2016 May;35(3):153-66. doi: 10.1007/s12664-016-0647-y
  2. Kotan R, Peto K, Deak A, Szentkereszty Z, Nemeth N. Hemorheological and Microcirculatory Relations of Acute Pancreatitis. Metabolites. 2022 Dec 20;13(1):4. doi: 10.3390/metabo13010004
  3. Kang R, Lotze MT, Zeh HJ, Billiar TR, Tang D. Cell death and DAMPs in acute pancreatitis. Mol Med. 2014 Oct 29;20(1):466-77. doi: 10.2119/molmed.2014.00117
  4. Minkov GA, Halacheva KS, Yovtchev YP, Gulubova MV. Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis. Pancreas. 2015 Jul;44(5):713-17. doi: 10.1097/MPA.0000000000000329
  5. Pădureanu V, Florescu DN, Pădureanu R, Ghenea AE, Gheonea DI, Oancea CN. Role of antioxidants and oxidative stress in the evolution of acute pancreatitis (Review). Exp Ther Med. 2022 Mar;23(3):197. doi: 10.3892/etm.2022.11120
  6. Potapnev MP. Cytokine storm: causes and consequences. Immunologiia. 2021;42(2):175-88.(In Russ.)
  7. Kudelich OA, Kondratenko GG, Yudina OA. Motolyanets PM. Multivariate analysis of factors associated with immediate causes of death in severe acute pancreatitis Novosti Khirurgii. 2014;22(4):416-27. doi: 10.18484/2305-0047.2014.4.416 (In Russ)
  8. Potapnev MP, Zagorodny GM, Krivenko SI, Bogdan VG, Svirsky AO, Yasyukevich AS, Asaevich VI, Bukach DV, Eismont O.L. Modern aspects of the use of plasma enriched in soluble platelet factors in the treatment of injuries and diseases of the musculoskeletal system. Sports Medicine: Research and Practice. 2019;9(4):33-45. doi: 10.17238/ISSN2223-2524.2019.4.33 (In Russ.)
  9. Renn TY, Kao YH, Wang CC, Burnouf T. Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model. Vox Sang. 2015 Aug;109(2):138-47. doi: 10.1111/vox.12264
  10. Lana JF, Huber SC, Purita J, Tambeli CH, Santos GS, Paulus C, Annichino-Bizzacchi JM. Leukocyte-rich PRP versus leukocyte-poor PRP - The role of monocyte/macrophage function in the healing cascade. J Clin Orthop Trauma. 2019 Oct;10(Suppl 1):S7-S12. doi: 10.1016/j.jcot.2019.05.008
  11. Potapnev MP, Arabey AA, Kondratenko GG, Troyanov AA, Kosmacheva SM, Ihnatsenko SI, Kakhno AA, Danilkovich NN, Krivenko SI, Nazarova EA, Levandovskaya OV, Kopetski IS, Loginov VV. Soluble preparations of platelet growth factors and their medical implementation Zdravookhranenie. 2014;9:32-40. https://www.zdrav.by/category/nomera-zhurnalov/9-sentyabr-2014 (In Russ.)
  12. Yamaguchi R, Terashima H, Yoneyama S, Tadano S, Ohkohchi N. Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J Surg Res. 2012 Apr;173(2):258-66. doi: 10.1016/j.jss.2010.10.001
  13. Asakawa T, Matsushita S. Coloring Condition of Thiobarbituric Acid Test for Detecting Lipid Hydroperoxides. Lipids. 1980;15(3):137-40. doi: 10.1007/BF02540959
  14. Kudelich OA, Kondratenko GG , Letkovskaya TA, Potapnev MP, Nerovnya AM, Stepuro OA. Morphological Substantiation of Severe Acute Pancreatitis Model. Khirurgiia. Vostochnaia Evropa. 2022;11(4):490-502 (In Russ.)
  15. Ho-Tin-Noé B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost. 2011 Jul;9(Suppl 1):56-65. doi: 10.1111/j.1538-7836.2011.04317.x
  16. Schlyakhova MA, Marijko VA, Kazakov MS, Features of changes in platelet growth of hematopoiesis in severe acute pancreatitis. Vestn Novykh Med Tekhnologii. 2019;13(6):75-79. doi: 10.24411/2075-4094-2019-16582 (In Russ.)
  17. Starodubtseva MN. Dual role of peroxynitrite in organism. Problemy Zdorov’ia i Ekologii. 2004;1(1):35-41. https://journal.gsmu.by/jour/article/view/2228/1952 (In Russ)
Address for correspondence:
220116, Republic of Belarus,
Minsk, Dzerzhinsky Ave. 83,
Belarusian State Medical University,
Department of Surgery and Transplantation,
tel. mob.: +375 29 1280783,
e-mail: kudelichsurg@gmail.com,
Kudelich Oleg Arkadievich
Information about the authors:
Kudelich Oleg A., PhD, Associate Professor of the Department of Surgery and Transplantology, Belarusian State Medical University, Minsk, Republic of Belarus.
https://orcid.org/0000-0003-0569-3427
Kondratenko Gennady G., MD, Professor, Department of Surgery and Transplantology, Belarusian State Medical University, Minsk, Republic of Belarus.
https://orcid.org/0000-0001-5295-1068
Potapnev Mikhail P., MD, Head of the Department of Cellular Biotechnologies and Medical Biotechnologies, Republican Scientific and Practical Center for Transfusiology and Medical Biotechnologies, Ministry of Health of the Republic of Belarus, Minsk, Republic of Belarus.
https://orcid.org/0000-0002-6805-1782

A.A. SEMAGIN 2, O.P. LUKIN 1, 2, A.A. FOKIN 1

ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING EMERGENCY PERCUTANEOUS CORONARY INTERVENTION AFTER CORONARY ARTERY BYPASS GRAFTING

Federal State Budgetary Educational Institution of Higher Professional Education
«South Ural State Medical University» of the Ministry of Health of the Russian Federation 1,
Federal State Budgetary Institution «Federal Center for Cardiovascular Surgery»
of the Ministry of Health of the Russian Federation 2, Chelyabinsk,
Russian Federation

Objective. To study the rate of long-term mortality and major adverse cardiovascular events within 10 years in patients undergoing emergency endovascular myocardial revascularization in the early postoperative period after planned coronary artery bypass surgery.
Methods. From 2011 to 2020 8801 patients underwent isolated coronary artery bypass grafting in the Federal State Budgetary Institution «FTSSSH» of the Ministry of Health of the Russian Federation in the city of Chelyabinsk. Due to signs of acute myocardial ischemia, 196 (2.23%) patients underwent emergency coronary angiography. Inclusion criteria in the study were as follows: patients (n=60; 0.68%) with a stable form of cardiac ischemia, who underwent emergency stenting due to acute grafts dysfunction after elective coronary artery bypass grafting based on coronary angiography. Exclusion criteria: patients who underwent urgent coronary artery bypass grafting, patients from the endovascular treatment group (n=6/10%) who deceased in the clinic within 30 days, patients with whom contact was lost after their discharge from the hospital (n=14/23,3%). Mortality has long been used as a primary end point for randomized controlled trials in critical care; cardiovascular events was considered as the secondary endpoint. To conduct a comparative analysis by random number generation, group II (n=60) consisting of patients with an uncomplicated postoperative period was formed. The exclusion criteria were just the same (deceased in the clinic n=1/1.6% and loss of communication after discharge from the hospital n=6/10%). After application of exclusion/inclusion criteria, group I included 40 patients and group II 53 patients. To ascertain patient reports of problems after discharge the telephone interviews have been conducted.
Results. When comparing the long-term total mortality rate in patients of group I (106.3±5.9 months) and group II (87.5±3.8 months), no statistically significant differences were found (p=0.737) in the incidence of major adverse cardiovascular events in Group I and Group II. There were also no statistically significant differences in vascular events in group I and group II, 111.5±4.8 months and 87.8±4.2 months, respectively (p=0.582). When conducting a multivariate Cox regression analysis in group I, this study shows that increasing age in 1 year significantly contribute to a fatal outcome in 1,361 fold (p=0,015), a decrease in LV EF by 1% - by 1/0.854 fold (p=0.012), with an increase in time from the first result of the analysis of Troponin I to stenting procedure for 1 hour by 1.029 folds (p=0.023).
Conclusion. When comparing long-term mortality rate and adverse cardiovascular events in the group of patients undergoing emergency stenting with the control group, no statistically significant difference was found. Factors that increase the risk of lethality in the long-term period in the stenting group were: the patient’s age, left ventricular ejection fraction in the preoperative period, the time elapsed from the results of the first Troponin I test to stenting procedure.

Keywords: coronary artery bypass, myocardial infarction, postoperative complications
p. 16-25 of the original issue
References
  1. Preußer MJ, Landwehrt J, Mastrobuoni S, Biancari F, Dakkak AR, Alshakaki M, Martens S, Dell’Aquila AM. Survival results of postoperative coronary angiogram for treatment of perioperative myocardial ischaemia following coronary artery bypass grafting: a single-centre experience. Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):237-42. doi: 10.1093/icvts/ivx317
  2. Thielmann M, Sharma V, Al-Attar N, Bulluck H, Bisleri G, Bunge JJH, Czerny M, Ferdinandy P, Frey UH, Heusch G, Holfeld J, Kleinbongard P, Kunst G, Lang I, Lentini S, Madonna R, Meybohm P, Muneretto C, Obadia JF, Perrino C, Prunier F, Sluijter JPG, Van Laake LW, Sousa-Uva M, Hausenloy DJ. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery. Eur Heart J. 2017 Aug 14;38(31):2392-407. doi: 10.1093/eurheartj/ehx383
  3. Gaudino M, Nesta M, Burzotta F, Trani C, Coluccia V, Crea F, Massetti M. Results of emergency postoperative re-angiography after cardiac surgery procedures. Ann Thorac Surg. 2015 May;99(5):1576-82. doi: 10.1016/j.athoracsur.2014.12.063
  4. Steuer J, Bjerner T, Duvernoy O, Jidéus L, Johansson L, Ahlström H, Stahle E, Lindahl B. Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J. 2004 Aug;25(15):1293-99. doi: 10.1016/j.ehj.2004.05.015
  5. Àðãóíîâà ÞÀ, Ëàðèîíîâ ÌÂ. Ïåðèîïåðàöèîííûé èíôàðêò ìèîêàðäà ïðè âûïîëíåíèè êîðîíàðíîãî øóíòèðîâàíèÿ. Îñíîâíûå ïîäõîäû ê äèàãíîñòèêå è ïðîôèëàêòèêå. Ðîñ Êàðäèîë Æóðí. 2019;(8):124-31. doi: 10.15829/1560-4071-2019-8-124-131
  6. Biancari F, Anttila V, Dell’Aquila AM, Airaksinen JKE, Brascia D. Control angiography for perioperative myocardial Ischemia after coronary surgery: meta-analysis. J Cardiothorac Surg. 2018 Feb 27;13(1):24. doi: 10.1186/s13019-018-0710-0
  7. Thielmann M, Massoudy P, Schmermund A, Neuhäuser M, Marggraf G, Kamler M, Herold U, Aleksic I, Mann K, Haude M, Heusch G, Erbel R, Jakob H. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J. 2005 Nov;26(22):2440-47. doi: 10.1093/eurheartj/ehi437
  8. Holmvang L, Jurlander B, Rasmussen C, Thiis JJ, Grande P, Clemmensen P. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest. 2002 Jan;121(1):103-11. doi: 10.1378/chest.121.1.103
  9. Davierwala PM, Verevkin A, Leontyev S, Misfeld M, Borger MA, Mohr FW. Impact of expeditious management of perioperative myocardial ischemia in patients undergoing isolated coronary artery bypass surgery. Circulation. 2013 Sep 10;128(11 Suppl 1):S226-34. doi: 10.1161/CIRCULATIONAHA.112.000347
  10. Petäjä L, Salmenperä M, Pulkki K, Pettilä V. Biochemical injury markers and mortality after coronary artery bypass grafting: a systematic review. Ann Thorac Surg. 2009 Jun;87(6):1981-92. doi: 10.1016/j.athoracsur.2008.12.063
  11. Sef D, Szavits-Nossan J, Predrijevac M, Golubic R, Sipic T, Stambuk K, Korda Z, Meier P, Turina MI. Management of perioperative myocardial ischaemia after isolated coronary artery bypass graft surgery. Open Heart. 2019 May 8;6(1):e001027. doi: 10.1136/openhrt-2019-001027. eCollection 2019.
  12. Onorati F, De Feo M, Mastroroberto P, Cristodoro L, Pezzo F, Renzulli A, Cotrufo M. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg. 2005 Mar;79(3):837-45. doi: 10.1016/j.athoracsur.2004.07.060
  13. Thielmann M, Massoudy P, Jaeger BR, Neuhäuser M, Marggraf G, Sack S, Erbel R, Jakob H. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2006 Jul;30(1):117-25. doi: 10.1016/j.ejcts.2006.03.062
  14. Rasmussen C, Thiis JJ, Clemmensen P, Efsen F, Arendrup HC, Saunamäki K, Madsen JK, Pettersson G. Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-re-vascularization. Eur J Cardiothorac Surg. 1997 Dec;12(6):847-52. doi: 10.1016/s1010-7940(97)00268-6
  15. Narayan P, Bandyopadhyay M, Khan MW, Sarkar K. Angiography for management of perioperative myocardial ischemia: does it have any role? Innovations (Phila). 2014 Sep-Oct;9(5):375-78; discussion 378. doi: 10.1097/IMI.0000000000000089
  16. Laflamme M, DeMey N, Bouchard D, Carrier M, Demers P, Pellerin M, Couture P, Perrault LP. Management of early postoperative coronary artery bypass graft failure. Interact Cardiovasc Thorac Surg. 2012 Apr;14(4):452-56. doi: 10.1093/icvts/ivr127
  17. Alam SR, Stirrat C, Spath N, Zamvar V, Pessotto R, Dweck MR, Moore C, Semple S, El-Medany A, Manoharan D, Mills NL, Shah A, Mirsadraee S, Newby DE, Henriksen PA. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6
Address for correspondence:
454003, Russian Federation,
Chelyabinsk, avenue Hero of Russia Rodionova E.N., 2,
Federal State Institution «Federal Centre for Cardiovascular Surgery,
the Ministry of Health of the Russian Federation,
tel.: +79823135426,
e-mail: AASemagin@gmail.com,
Semagin Aleksei A.
Information about the authors:
Semagin Aleksey A., PhD, Cardio-Vascular Surgeon; Federal State Budgetary Institution «Federal Center for Cardiovascular Surgery» of the Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation.
https://orcid.org/0000-0002-1011-2300
Lukin Oleg P., MD, Chief Physician, Professor of the Department of Hospital Surgery; Federal State Budgetary Institution «Federal Center for Cardiovascular Surgery» of the Ministry of Health of the Russian Federation, Federal State Budgetary Educational Institution of Higher Professional Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation.
https://orcid.org/0000-0003-3162-1523
Fokin Aleksey A., MD, Professor, Head of the Department of Surgery of the Institute of Additional Professional Education; Federal State Budgetary Educational Institution of Higher Professional Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation.
https://orcid.org/0000-0001-7806-2357

S.G. GAVRILOV, I.S. LEBEDEV, A.V. VASILIEV, N.YU. MISHAKINA

RATIONALE OF VENOUS OBSTRUCTION STENTING

Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow,
Russian Federation

Objective. The aim of this study is to substantiate the expediency of using stenting in patients with chronic venous obstruction, based on literature data and real clinical practice.
Methods. A systematic search of current literature on the application of various stents in the treatment of chronic thrombotic and non-thrombotic obstruction of the iliac veins was conducted by browsing the Pubmed, MEDLINE è Google Scholar.
In addition to clinical efficacy, economic aspects of the application of venous stenting in the treatment of chronic venous obstruction have been studied. Clinical observations are presented demonstrating the possibilities of iliac vein stenting in patients with post-thrombotic disease, a combination of May-Turner syndromes and pelvic congestion syndrome.
Results. Currently, both classical and special venous stents are used for stenting of large veins. The latter have greater flexibility and radial strength, and their use is not accompanied by such complications as stent occlusion of the contralateral common iliac vein and conical narrowing of the ends of the stent. The literature data indicate the high efficiency of stenting in restoration of the iliac vein lumen in thrombotic and non-thrombotic obstructions of the iliac veins, and stent patency ranges from 79 to 100% within 1-3 years. The authors report on the relief of edematous and pain syndromes, and healing of trophic ulcers in 70-100% of patients. Studies comparing the cost of venous stenting and standard conservative treatment indicate that the use of endovascular intervention is accompanied by a significant reduction in the economic costs of the treatment, a reduction of expenditures of a medical institution, and a decrease in the period of temporary disability among patients. Clinical observations presented in the study are based on the real clinical practice of the authors of this work and confirm the literature data.
Conclusion. The application of venous stenting is an effective and safe method of restoring the patency of the main veins, which can relieve the clinical manifestations of chronic venous insufficiency and pelvic venous congestion syndrome. This method is also accompanied by a decrease in economic costs in the treatment of patients with chronic venous obstructions.

Keywords: chronic venous obstruction, venous stenting, post-thrombotic disease, May-Turner syndrome, economic feasibility
p. 26-38 of the original issue
References
  1. Jayaraj A, Raju S. Iliocaval Venous Obstruction. In: Sidawy AN, Perler BA, eds. Rutherford’s vascular surgery and endovascular therapy. Philadelphia, PA: Elsevier; 2019. ð. 6899-932.
  2. Rognoni C, Lugli M, Maleti O, Tarricone R. Venous stenting for patients with outflow obstruction and leg ulcers: cost-effectiveness and budget impact analyses. J Comp Eff Res. 2020 Jul;9(10):705-20. doi: 10.2217/cer-2020-0030
  3. Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007 Nov;46(5):979-90. doi: 10.1016/j.jvs.2007.06.046
  4. Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg. 2011 Mar;53(3):706-12. doi: 10.1016/j.jvs.2010.09.011
  5. Raju S. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg. 2013 Apr;57(4):1163-69. doi: 10.1016/j.jvs.2012.11.084
  6. Mickley V, Friedrich JM, Hutschenreiter S, Sunder-Plassmann L. Long-term results of percutaneous transluminal angioplasty and stent implantation in venous stenoses following transfemoral thrombectomy. Vasa. 1993;22(1):44-52.
  7. Zollikofer CL, Schoch E, Stuckmann G, Espinosa N, Stiefel M. Percutaneous transluminal treatment of stenoses and obstructions in the venous system using vascular endoprostheses (stents). Schweiz Med Wochenschr. 1994 Jun 11;124(23):995-1009. [Article in German]
  8. Williams ZF, Dillavou ED. A systematic review of venous stents for iliac and venacaval occlusive disease. J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):145-153. doi: 10.1016/j.jvsv.2019.08.015
  9. Majeed GM, Lodhia K, Carter J, Kingdon J, Morris RI, Gwozdz A, Saratzis A, Saha P. A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents. J Endovasc Ther. 2022 Jun;29(3):478-492. doi: 10.1177/15266028211057085
  10. Shamimi-Noori SM, Clark TWI. Venous Stents: Current Status and Future Directions. Tech Vasc Interv Radiol. 2018 Jun;21(2):113-16. doi: 10.1053/j.tvir.2018.03.007
  11. Jayaraj A, Raju S. The venous stent: Is it primetime yet? In: Chaar CI, ed. Current management of venous diseases. Springer, Cham; 2018. ð. 489-96. doi: 10.1007/978-3-319-65226-9_37
  12. Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg. 1995 Feb;21(2):307-12; discussion 313. doi: 10.1016/s0741-5214(95)70271-7
  13. Neglén P, Thrasher TL, Raju S. Venous outflow obstruction: An underestimated contributor to chronic venous disease. J Vasc Surg. 2003 Nov;38(5):879-85. doi: 10.1016/s0741-5214(03)01020-6
  14. Raju S. Treatment of iliac-caval outflow obstruction. Semin Vasc Surg. 2015 Mar;28(1):47-53. doi: 10.1053/j.semvascsurg.2015.07.001
  15. Dabir D, Feisst A, Thomas D, Luetkens JA, Meyer C, Kardulovic A, Menne M, Steinseifer U, Schild HH, Kuetting DLR. Physical Properties of Venous Stents: An Experimental Comparison. Cardiovasc Intervent Radiol. 2018 Jun;41(6):942-50. doi: 10.1007/s00270-018-1916-1
  16. Sayed MH, Salem M, Desai KR, O’Sullivan GJ, Black SA. A review of the incidence, outcome, and management of venous stent migration. J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):482-90. doi: 10.1016/j.jvsv.2021.07.015
  17. Badesha AS, Bains PRS, Bains BRS, Khan T. A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):267-82.e4. doi: 10.1016/j.jvsv.2021.04.014
  18. Raju S, Darcey R, Neglén P. Unexpected major role for venous stenting in deep reflux disease. J Vasc Surg. 2010 Feb;51(2):401-8; discussion 408. doi: 10.1016/j.jvs.2009.08.032
  19. Dake MD, O’Sullivan G, Shammas NW, Lichtenberg M, Mwipatayi BP, Settlage RA; VERNACULAR Trial Investigators. Three-Year Results from the Venovo Venous Stent Study for the Treatment of Iliac and Femoral Vein Obstruction. Cardiovasc Intervent Radiol. 2021 Dec;44(12):1918-29. doi: 10.1007/s00270-021-02975-2
  20. Razavi M, Marston W, Black S, Bentley D, Neglén P. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):192-200. doi: 10.1016/j.jvsv.2017.10.014
  21. Gloviczki P, Kalra M, Duncan AA, Oderich GS, Vrtiska TJ, Bower TC. Open and hybrid deep vein reconstructions: to do or not to do? Phlebology. 2012 Mar;27 Suppl 1:103-6. doi: 10.1258/phleb.2012.012s29
  22. Gavrilov SG, Vasilyev AV, Krasavin GV, Moskalenko YP, Mishakina NY. Endovascular interventions in the treatment of pelvic congestion syndrome caused by May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1049-57. doi: 10.1016/j.jvsv.2020.02.012
  23. van Vuuren TMAJ, Kurstjens RLM, Wittens CHA, van Laanen JHH, de Graaf R. Illusory Angiographic Signs of Significant Iliac Vein Compression in Healthy Volunteers. Eur J Vasc Endovasc Surg. 2018 Dec;56(6):874-79. doi: 10.1016/j.ejvs.2018.07.022
  24. Jayaraj A, Powell T, Raju S. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1408-15. doi: 10.1016/j.jvsv.2021.05.008
  25. Akesson H, Brudin L, Dahlström JA, Eklöf B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990 Feb;4(1):43-48. doi: 10.1016/s0950-821x(05)80037-4
  26. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 200 4 Jan;239(1):118-26. doi: 10.1097/01.sla.0000103067.10695.74
  27. Jayaraj A, Noel C, Kuykendall R, Raju S. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting. J Vasc Surg Venous Lymphat Disord. 2021 Mar;9(2):393-400.e2. doi: 10.1016/j.jvsv.2020.08.020
  28. Rizvi SA, Ascher E, Hingorani A, Marks N. Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):457-63. doi: 10.1016/j.jvsv.2018.02.004
  29. Ye K, Shi H, Yin M, Qin J, Yang X, Liu X, Jiang M, Lu X. Treatment of Femoral Vein Obstruction Concomitant with Iliofemoral Stenting in Patients with Severe Post-thrombotic Syndrome. Eur J Vasc Endovasc Surg. 2018 Feb;55(2):222-28. doi: 10.1016/j.ejvs.2017.11.029
  30. Gianesini S, Obi A, Onida S, Baccellieri D, Bissacco D, Borsuk D, Campisi C, Campisi CC, Cavezzi A, Chi YW, Chunga J, Corda D, Crippa A, Davies A, De Maeseneer M, Diaz J, Ferreira J, Gasparis A, Intriago E, Jawien A, Jindal R, Kabnick L, Latorre A, Lee BB, Liew NC, Lurie F, Meissner M, Menegatti E, Molteni M, Morrison N, Mosti G, Narayanan S, Pannier F, Parsi K, Partsch H, Rabe E, Raffetto J, Raymond-Martimbeau P, Rockson S, Rosukhovski D, Santiago FR, Schul A, Schul M, Shaydakov E, Sibilla MG, Tessari L, Tomaselli F, Urbanek T, van Rijn MJ, Wakefield T, Wittens C, Zamboni P, Bottini O. Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23-25 January 2019. Phlebology. 2019 Sep;34(1 Suppl):4-66. doi: 10.1177/0268355519870690
  31. Gagne PJ, Gagne N, Kucher T, Thompson M, Bentley D. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):45-55. doi: 10.1016/j.jvsv.2018.07.016
  32. Hartung O, Loundou AD, Barthelemy P, Arnoux D, Boufi M, Alimi YS. Endovascular management of chronic disabling ilio-caval obstructive lesions: long-term results. Eur J Vasc Endovasc Surg. 2009 Jul;38(1):118-24. doi: 10.1016/j.ejvs.2009.03.004
  33. Rossi FH, Kambara AM, Izukawa NM, Rodrigues TO, Rossi CB, Sousa AG, Metzger PB, Thorpe PE. Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):183-91. doi: 10.1016/j.jvsv.2017.11.003
  34. Sarici IS, Yanar F, Agcaoglu O, Ucar A, Poyanli A, Cakir S, Aksoy SM, Kurtoglu M. Our early experience with iliofemoral vein stenting in patients with post-thrombotic syndrome. Phlebology. 2014 Jun;29(5):298-303. doi: 10.1177/0268355513477641
  35. Gavrilov SG. Combination of May-Thurner syndrome and pelvic congestion syndrome: terra incognita. Phlebolymphology. 2021;28(3):90-102. https://www.phlebolymphology.org/wp-content/uploads/2022/01/Phlebolymphology-105.pdf
  36. Raju S, Owen S Jr, Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg. 2002 Jan;35(1):8-15. doi: 10.1067/mva.2002.121054
  37. van Vuuren TMAJ, Doganci S, Wittens CHA. Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent. J Vasc Surg Venous Lymphat Disord. 2018 May;6(3):321-29. doi: 10.1016/j.jvsv.2017.09.013
  38. Lichtenberg M, Breuckmann F, Stahlhoff WF, Neglén P, Rick G. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes. Vasa. 2018 Oct;47(6):475-81. doi: 10.1024/0301-1526/a000731
  39. Oguzkurt L, Tercan F, Ozkan U, Gulcan O. Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up. Eur J Radiol. 2008 Dec;68(3):487-92. doi: 10.1016/j.ejrad.2007.08.019
  40. Santoshi RKN, Lakhanpal S, Satwah V, Lakhanpal G, Malone M, Pappas PJ. Iliac vein stenosis is an underdiagnosed cause of pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):202-211. doi: 10.1016/j.jvsv.2017.09.007
  41. Lakhanpal G, Kennedy R, Lakhanpal S, Sulakvelidze L, Pappas PJ. Pelvic venous insufficiency secondary to iliac vein stenosis and ovarian vein reflux treated with iliac vein stenting alone. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1193-98. doi: 10.1016/j.jvsv.2021.03.006
  42. Daugherty SF, Gillespie DL. Venous angioplasty and stenting improve pelvic congestion syndrome caused by venous outflow obstruction. J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):283-89. doi: 10.1016/j.jvsv.2015.01.003
  43. Tangney E, O’Donnell T, Iafrati M. Cost and Benefit Analysis of Stenting Versus Compression Therapy for Patients With Chronic Total Venous Occlusion. J Vasc Surg Venous Lymphat Disord. 2016;4(1):137. doi: 10.1016/j.jvsv.2015.10.014
Address for correspondence:
119049, Russian Federation,
Moscow, Leninsky prospect, 10, 5,
tel. 8 916 929 99 47,
e-mail: gavriloffsg@mail.ru,
Sergey G. Gavrilov
Information about the authors:
Gavrilov Sergey G., MD, Professor, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
http://orcid.org/0000-0002-2307-2176
Lebedev Igor S., MD, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0001-7956-3807
Vasiliev Alexey V., Internetional Surgeon, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
Mishakina Nadezhda Y., Ultrasound Diagnostics Doctor, Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0002-3626-0299

S.I. PIMANOV 1, I.A. LIUTSKO 2, S.V. MALASHENKA 3, K.V. MOSKALEV 1, SAKR ALI 1, P.P. LAKISAU 3, V.A. DUBNIAK 1

XANTHOGRANULOMATOUS CHOLECYSTITIS: A RARE DISEASE WITH ATYPICAL ASSYMPTOM COURSE

Vitebsk State Medical University 1,
Vitebsk Regional Clinical Hospital 2,
Vitebsk Regional Clinical Pathological Bureau 3, Vitebsk,
Republic of Belarus

Xanthogranulomatous cholecystitis is a rare form of inflammation of the gallbladder, the characteristic morphological feature of which is thickening of the wall, its focal or diffuse destructive inflammatory process, followed by pronounced proliferative fibrosis, infiltration by macrophages, giant multinucleated and foamy cells, and xanthomas or ceroid cells are ultimately formed granulomas. The purpose of this work was to demonstrate the diagnosis and surgical treatment of a rare variant of gallbladder disease – xanthogranulomatous cholecystitis – in its atypical asymptomatic clinical course. A case of xanthogranulomatous cholecystitis is described. A 75-year-old patient was admitted in a planned manner for surgical treatment of a recurrence of an inguinal-scrotal hernia on the right. According to complaints, anamnesis and objective examination, there were no signs of gallbladder diseases. There were no pathological changes in the general blood test. An ultrasound examination revealed a pronounced thickening of the gallbladder wall and calculi in its cavity, as well as the presence of areas of reduced echogenicity in the gallbladder wall. Calculi were determined in the cavity of the gallbladder; the wall of the gallbladder was markedly thickened with the presence of areas of reduced echogenicity. There was no blood flow in the bladder wall according to color Doppler mapping. According to the results of computed tomography, thickening of the bladder wall was also recorded; however, it was not possible to make a differential diagnosis of xanthogranulomatous cholecystitis and gallbladder cancer. After cholecystectomy, an unexpected morphological finding was the presence of a pronounced inflammatory process with necrosis of the mucous membrane of the gallbladder wall. Probably, in rare cases, xanthogranulomatous cholecystitis with acute inflammation may be oligosymptomatic or asymptomatic.

Keywords: xanthogranulomatous cholecystitis, acute cholecystitis, ultrasound diagnostics, gallbladder, xanthoma, ceroid
p. 39-47 of the original issue
References
  1. Krylov N., Vinnichuk D. Xanthogranulomatous cholecystitis: difficulties in diagnosis and treatment. Doctor. 2014;4:83-84. (in Russ.) http://gastro.rusvrach.ru/archive/vrach-2014-04-25.pdf
  2. Lee A, Forse CL, Walsh C, Bertens K, Balaa F. Diagnostic and surgical dilemma of cholecystitis that mimics cancer – A case report of xanthogranulomatous cholecystitis. Int J Surg Case Rep. 2020;77:459-62. doi: 10.1016/j.ijscr.2020.11.030
  3. Takahashi K, Oka K, Hakozaki H, Kojima M. Ceroid-like histiocytic granuloma of gall-bladder – a previously undescribed lesion. Acta Pathol Jpn. 1976 Jan;26(1):25-46. doi: 10.1111/j.1440-1827.1976.tb03291.x.
  4. Nacif LS, Hessheimer AJ, Rodríguez Gómez S, Montironi C, Fondevila C. Infiltrative xanthogranulomatous cholecystitis mimicking aggressive gallbladder carcinoma: A diagnostic and therapeutic dilemma. World J Gastroenterol. 2017 Dec 28;23(48):8671-78. doi: 10.3748/wjg.v23.i48.8671
  5. Yucel O, Uzun MA, Tilki M, Alkan S, Kilicoglu ZG, Goret CC. Xanthogranulomatous Cholecystitis: Analysis of 108 Patients. Indian J Surg. 2017 Dec;79(6):510-14. doi: 10.1007/s12262-016-1511-0
  6. Singh VP, Rajesh S, Bihari C, Desai SN, Pargewar SS, Arora A. Xanthogranulomatous cholecystitis: What every radiologist should know. World J Radiol. 2016 Feb 28;8(2):183-91. doi: 10.4329/wjr.v8.i2.183
  7. Xiao J, Zhou R, Zhang B, Li B. Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogranulomatous cholecystitis: A retrospective cohort study of 240 patients. Cancer Med. 2022 Jan;11(1):176-82. doi: 10.1002/cam4.4442
  8. Bo X, Chen E, Wang J, Nan L, Xin Y, Wang C, Lu Q, Rao S, Pang L, Li M, Lu P, Zhang D, Liu H, Wang Y. Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. Ann Transl Med. 2019 Nov;7(22):627. doi: 10.21037/atm.2019.11.35
  9. Pimanov S.I. Ultrasonic diagnostics in gastroenterology. Moscow: Prakticheskaia meditsina; 2016. 416 p. (in Russ.)
  10. Suzuki H, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer. World J Gastroenterol 2015 Sep 21;21(35): 10166-73. doi: 10.3748/wjg.v21.i35.10166.
  11. Shcherbinina MB, Korolenko AS, Kornilov BE, Zakrevskaya EV. Xanthogranulomatous cholecystitis: a clinical case. Contemporary gastroenterology. 2006;2(28):103–107. (in Russ.) http://www.vitapol.com.ua/user_files/pdfs/gastro/272794719739150_15062009112857.pdf
  12. Makimoto S, Takami T, Hatano K, Kataoka N, Yamaguchi T, Tomita M, Shono Y. Xanthogranulomatous cholecystitis: a review of 31 patients. Surg Endosc. 2021 Jul; 35(7):3874-80. doi: 10.1007/s00464-020-07828-6
  13. Feng L, You Z, Gou J, Liao E, Chen L. Xanthogranulomatous cholecystitis: experience in 100 cases. Ann Transl Med. 2020 Sep;8(17):1089. doi: 10.21037/atm-20-5836
Address for correspondence:
210009, Republic of Belarus,
Vitebsk, Frunze Ave., 27,
Vitebsk State Medical University,
Department of Internal Medicine and Ultrasound Diagnostics of the FPC and PC,
e-mail: pimanovs@tut.by,
tel.: +375298996852, +375296857177,
Pimanov Sergei I.
Information about the authors:
Pimanov Sergey I., MD, Professor, Head of the Department of Internal Diseases and Ultrasound Diagnostics, Faculty of Advanced Training and Retraining of Personnel, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0001-6067-3600
Lyutsko Igor A., Surgeon, Vitebsk Regional Clinical Hospital, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0003-4580-7038
Malashenko Sergey V. Head of Vitebsk Regional Clinical Pathological and Anatomical Bureau, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0002-5448-6179
Moskalev Konstantin V. Associate Professor of the Department of Hospital Surgery with the Course of FPC and PC, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0001-8626-0249
Saqr Ali, Resident of the Department of Hospital Surgery with the Course of FPC and PC of Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0002-2142-9581
Lakisov Pavel P., Head of the Pathoanatomical Department of General Pathology of Vitebsk Regional Clinical Pathological Bureau, Vitebsk, Republic of Belarus.
Dubnyak Victoria A., Student-Subordinator of the Department of Hospital Surgery with the Course of FPC and PC, Vitebsk State Medical University, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0001-5735-0093

R.Y. ALIYEV 1, 2, À.Ì. JAFAROV 2, K.M. MAMMADOV 2, N.Y. BAYRAMOV 1

ENDOBILIARY SURGERY OF MECHANICAL JAUNDICE OF TUMOR GENESIS

Department of Surgical Diseases-I Azerbaijan Medical University 1,
Military Hospital of the Head Military-Medical Department of the State Security Service of the Republic of Azerbaijan 2, Baku,
Republic of Azerbaijan

Objective. To present the results of minimally invasive biliary endo-interventions in patients who categorically refused radical, extended and palliative open surgeries, as well as inoperable and incurable patients with obstructive jaundice of tumor origin.
Methods. A multi-stage diagnostic process with the aim of final verification of the underlying disease and determination of its stage has been carried out. In patients (n=38) with inoperable malignant neoplasms of the hepatopancreatoduodenobiliary zone complicated by obstructive jaundice, the minimally invasive endoscopic interventions were performed: nasobiliary, percutaneous-transhepatic biliary drainage, endoprosthetics of the extrahepatic bile ducts and electro- (photo) destruction of the large papilla.
Results. In contrast to plastic prostheses, after the use of metal self-expanding prostheses, the incidence of displacement, deformation, migration and blockages has significantly decreased. It was established that the best long-term results were obtained when choosing the most optimal endo-intervention, depending on the quality of its implementation, in cases of using metal stents in patients with a low localization of the tumor process and smaller sizes, a shorter anamnesis of obstructive jaundice, without concomitant diseases and dysfunction of vital organs, in persons of middle (40-50 yrs.) and relatively elderly (51-65 yrs) age.
Conclusion. In patients who categorically refused radical, vast and palliative open surgeries, as well as inoperable and incurable patients, minimally invasive endoscopic and percutaneous biliary interventions should be the method of choice for obstructive jaundice of malignant origin.

Keywords: obstructive jaundice, malignant tumor, nasobiliary drainage, arthroplasty of the common bile duct, tumor destruction
p. 48-56 of the original issue
References
  1. Borisov AE, Bereznikova EA, Levin LA. Rak zhelchnogo puzyrja i vnepechenochnyh zhelchnyh protokov V kn: Borisov AE, red. Rukovodstvo po hirurgii pecheni i zhelchevyvodjashhih putej: v 2 t. S-Petersburg, RF: Skifija; 2003; V.2. p. 51-84. (In Russ.)
  2. Borisova NA, Borisov AE, Kareev AV. Jendobiliarnye metody korrekcii mehanicheskoj zheltuhi. V kn: Borisov AE, red. Rukovodstvo po hirurgii pecheni i zhelchevyvodjashhih putej: v 2 t. S-Peterburg, RF: Skifija; 2003. V..2. p. 281-54. (In Russ.)
  3. Aksel’ EM, Davydov MI, Ushakova TI. Zlokachestvennye novoobrazovanija zheludochno-kishechnogo trakta: osnovnye statisticheskie pokazateli i tendencii. Sovrem Onkologija. 2001;3(4):141-45. https://modernonco.orscience.ru/1815-1434/issue/view/1445(In Russ.)
  4. Mihajlichenko VJu, Kisljakov VV, Reznichenko AM, Samarin SA. Sovremennye aspekty hirurgicheskogo lechenija sindroma mehanicheskoj zheltuhi. Sovrem Problemy Nauki i Obrazovanija. 2019;(3). https://science-ducation.ru/ru/ article/view?id=28755 (In Russ.)
  5. Tseimakh AÅ, Lazarev ÀF, Bedian NÊ, Teplukhin VN, Mitshenko ÀN, Shoykhet IaN. Features of modern treatment of patients with obstruction of bile duct of neoplasmatic genesis. Rossiiskii onko-logicheskii zhurnal. (Russian Journal of Oncology). 2019;23(3–6): 149–157. doi: 10.18821/1028-9984-2019-23-3-6-149-157.(In Russ.)
  6. Glazer ES, Hornbrook MC, Krouse RS. A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. J Pain Symptom Manage. 2014 Feb;47(2):307-14. doi: 10.1016/j.jpainsymman.2013.03.013
  7. Alekseev KI. Miniinvazivnye khirurgicheskie tekhnologii s primeneniem samorasshiriaiushchikhsia metallicheskikh stentov pri mekhanicheskoi zheltukhe opukholevogo geneza: diss kand. med. nauk. Moscow? RF, 2016. 160 p. (In Russ.)
  8. Dumonceau JM, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, Costamagna G; European Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012 Mar;44(3):277-98. doi: 10.1055/s-0031-1291633
  9. Tilemisov SO, Hadzhibaev FA, Tilemisov RO. Miniinvazivnye metody dekompressii v lechenii mehanicheskoj zheltuhi zlokachestvennogo geneza. Vestn Jekstrennoj Mediciny. 2016;IX(1):28-32. ( In Russ.)
  10. Elwir S, Sharzehi K, Veith J, Moyer MT, Dye C, McGarrity T, Mathew A. Biliary stenting in patients with malignant biliary obstruction: comparison of double layer, plastic and metal stents. Dig Dis Sci. 2013 Jul;58(7):2088-92. doi: 10.1007/s10620-013-2607-z
  11. Walter T, Ho CS, Horgan AM, Warkentin A, Gallinger S, Greig PD, Kortan P, Knox JJ. Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol. 2013 Jan;24(1):113-21. doi: 10.1016/j.jvir.2012.09.019
  12. Gordon RL, Ring EJ, LaBerge JM, Doherty MM. Malignant biliary obstruction: treatment with expandable metallic stents--follow-up of 50 consecutive patients. Radiology. 1992 Mar;182(3):697-701. doi: 10.1148/radiology.182.3.1371362
  13. Coons H. Metallic stents for the treatment of biliary obstruction: a report of 100 cases. Cardiovasc Intervent Radiol. 1992 Nov-Dec;15(6):367-74. doi: 10.1007/BF02734120
  14. Hara K, Yamao K, Mizuno N, Hijioka S, Imaoka H, Tajika M, Tanaka T, Ishihara M, Okuno N, Hieda N, Yoshida T, Niwa Y. Endoscopic ultrasonography-guided biliary drainage: Who, when, which, and how? World J Gastroenterol. 2016 Jan 21;22(3):1297-303. doi: 10.3748/wjg.v22.i3.1297
  15. Khashab MA, Valeshabad AK, Afghani E, Singh VK, Kumbhari V, Messallam A, Saxena P, El Zein M, Lennon AM, Canto MI, Kalloo AN. A comparative evaluation of EUS-guided biliary drainage and percutaneous drainage in patients with distal malignant biliary obstruction and failed ERCP. Dig Dis Sci. 2015 Feb;60(2):557-65. doi: 10.1007/s10620-014-3300-6
  16. Wilcox CM, Kim H, Seay T, Varadarajulu S. Choice of plastic or metal stent for patients with jaundice with pancreaticobiliary malignancy using simple clinical tools: a prospective evaluation. BMJ Open Gastroenterol. 2015 Feb 9;2(1):e000014. doi: 10.1136/bmjgast-2014-000014. eCollection 2015.
  17. Sugiyama H, Tsuyuguchi T, Sakai Y, Nisikawa T, Miyazaki M, Yokosuka O. Preoperative drainage for distal biliary obstruction: endoscopic stenting or nasobiliary drainage? Hepatogastroenterology. 2013 Mar-Apr;60(122):231-34. doi: 10.5754/hge12621
  18. Gómez-Torres Gustavo Ángel, Hernández-García Fernando Santiago. Preoperative Biliary Drainage: Methods, Advantages, and Complications. In: Rodrigo L, ed. Bile Duct Cancer. doi: 10.5772/intechopen.83655
  19. Matsumoto K, Takeda Y, Onoyama T, Kawata S, Kurumi H, Koda H, Yamashita T, Isomoto H. Endoscopic treatment for distal malignant biliary obstruction. Ann Transl Med. 2017 Apr;5(8):190. doi: 10.21037/atm.2017.02.22
  20. Moy BT, Birk JW. An Update to Hepatobiliary Stents. J Clin Transl Hepatol. 2015 Mar;3(1):67-77. doi: 10.14218/JCTH.2015.00040
  21. Li J, Li T, Sun P, Yu Q, Wang K, Chang W, Song Z, Zheng Q. Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis. PLoS One. 2016 Feb 9;11(2):e0149066. doi: 10.1371/journal.pone.0149066. eCollection 2016.
  22. Lee TH, Moon JH, Park SH. Biliary stenting for hilar malignant biliary obstruction. Dig Endosc. 2020 Jan;32(2):275-86. doi: 10.1111/den.13549
Address for correspondence:
Az 102, Republic of Azerbaijan,
Baku City, Badamdar, st. Mektebli, 1,
Military Hospital
tel: +99450 348 92 55
e-mail: endosmed@mail.ru
Jafarov Adil Musa oghlu
Information about the authors:
Aliyev Rufat Yashar oglu, Associate Professor of the Department of Surgical Diseases-1 of the Azerbaijan Medical University, Head of the Main Military Medical Department of the State Security Service of the Republic of Azerbaijan, Major General of the Medical Service, Baku, Republic of Azerbaijan.
http://orcid.org/0000-0002-5484-1468
Jafarov Adil Musa oglu, ordinator of the Department of Endoscopy of the Military Hospital of the Main Military Medical Department of the State Security Service of the Republic of Azerbaijan, Baku, Republic of Azerbaijan.
http://orcid.org/0000-0002-6232-0961
Mammadov Kanan Majnun oglu, Head of the Military Hospital of the Main Military Medical Department of the State Security Service of the Republic of Azerbaijan, Captain of the Medical Service, Baku, Republic of Azerbaijan.
http://orcid.org/0000-0001-8733-2099
Bayramov Nuru Yusif oglu, Corresponding Member. ANAS, Professor, Head of the Department of Surgical Diseases-1 of the Azerbaijan Medical University, Baku, Republic of Azerbaijan.
http://orcid.org/0000-0001-6958-5412

I.A. MATVEEV 1, 2, B.K. GIBERT 1, 2, F.S. ALIYEV 1, N.A. BORODIN 1, A.I. MATVEEV 2, L.A. MOROZOVA 3, N.N. POVARNIN 3, T.I. PAYUSOVA 4

STUDY OF THE ACQUISITION OF EXPERIENCE IN PERFORMING LASER VAPORIZATION OF HEMORRHOIDS

Federal State Budgetary Educational Institution of Higher Education "Tyumen State Medical University" of the Ministry of Healthcare of the Russian Federation 1,
Tyumen Regional Clinical Hospital 2,
«NanoMed Plus» 3,
Federal State Autonomous Educational Institution of Higher
Education Tyumen State University 4, Tyumen,
Russian Federation

Objective. To study the set of experience of laser vaporization in the treatment of chronic hemorrhoids by the method of constructing learning curve
Methods. Based on 90 isolated LV performed by one surgeon, the process of gaining experience by constructing learning curves was studied. The criteria of mastery were the duration of the operation, the intensity of the pain syndrome, the frequency of postoperative bleeding.
Results. The duration of the period of mastering the experience, determined by the regression method, based on the time of the intervention, depending on the goal, was 4, 23 and 66 operations. On the basis of postoperative bleeding with the task of reducing their frequency by 2 times, performed by the CUSUM test, the period of LV development was 36 operations.
Discussion. The results of the study made it possible to explain the reasons for the differences in the duration of the experience of laser transmucous vaporization of hemorrhoids, depending on the chosen model for constructing the learning curve, the sign of experience, and the goals set for achieving it. The most objective way to study the experience of LV is CUSUM analysis of the frequency of postoperative bleeding
Conclusion. The use of various mathematical models and signs of experience allows you to build an objective graph of the learning curve and obtain the most reliable research results.

Keywords: laser vaporization of hemorrhoids, learning curve, results of laser vaporization, complications of laser vaporization
p. 57-64 of the original issue
References
  1. Titov AYu, Kostevich IV. Submucosal laser ablation of internal hemorrhoids Pirogov Russian Journal of Surgery = Khirurgiya. Zurnal im. N.I. Pirogova. 2020;(3):89 96. doi: 10.17116/hirurgia202003189 (In Russ.)
  2. Cherepenin MYu., Gorskiy VA, Armashov VP. Results of treatment of hemorrhoids by submucosal w-laser destruction of hemorrhoidal piles. Koloproktologia. 2020;19(2):104-111 DOI: 10.33878/2073-7556-2020-19-2-104-111. (In Russ.)
  3. Khitaryan AG, Alibekov AZ, Kovalev SA, Orekhov AA, Burdakov IYu, Golovina AA, Romodan NA. Results of the use of intranodal laser coagulation in patients with chronic internal hemorrhoids stage III. Koloproktologia. 2021;20(1):33-40. doi: 10.33878/2073-7556-2021-20-1-33-40 (In Russ)
  4. Katorkin SE, Korymasov EA, Sotnikov VM, Andreev NS, Krivoshchekov EN, Romanov VE. Modern principles of hemorrhoid treatment. Moscow. 2021 – 203 P. (In Russ)
  5. Longchamp G, Liot E, Meyer J, Toso C, Buchs NC, Ris F. Non-excisional laser therapies for hemorrhoidal disease: a systematic review of the literature. Lasers Med Sci. 2021 Apr;36(3):485-496. doi: 10.1007/s10103-020-03142-8.
  6. Naderan M, Shoar S, Nazari M, Elsayed A, Mahmoodzadeh H, Khorgami Z. A randomized controlled trial comparing laser intra-hemorrhoidal coagulation and Milligan-Morgan hemorrhoidectomy. J Investig Surg Off J Acad Surg Res. 2017;30(5):325–331
  7. Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF., Russell IT. Statistical assessment of the learning curves of health technologies. Health Technol Assess. 2001; 5: 71–79
  8. Valsamis EM, Chouari T, O’Dowd-Booth C, Rogers B, Ricketts D.. Learning curves in surgery: variables, analysis and applications. Postgrad Med J. 2018 Sep; 94 (1115):525-530. doi: 10.1136 / postgradmedj-2018-135880.
  9. Khan N, Abboudi H, Khan MS, Dasgupta P, Ahmed K. Measuring the surgical ‘learning curve’: methods, variables and competency. BJU Int. 2014; 113:504–508. doi: 10.1111/bju.12197
  10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla. 0000133083.54934.ae.
  11. Tyutyunnik PS, Khat’kov IE, Tsvirkun VV, Izrailov RE, Khisamov AA, Andrianov AV. Optimal model of learning curve through the example of laparoscopic pancreatoduodenectomy. Endoscopic Surgery. 2015;21(5):45 49. (In Russ.). doi: 10.17116/endoskop201521545-49
  12. Biau DJ, Resche-Rigon M, Godiris-Petit G, Nizard RS, Porcher R. Quality control of surgical and interventional procedures: a review of the CUSUM. Qual Saf Health Care. 2007 Jun;16(3):203-7. doi: 10.1136/qshc.2006.020776.
  13. Jackson T D, Wannares J J, Lancaster RT, Rattner DW, Hut MM. Does speed matter? The impact of operative time on outcome in laparoscopic surgery. February 2011; Surgical Endoscopy 25(7):2288-95. DOI: 10.1007/s00464-010-1550-8.
  14. Harrysson IJ, Cook J, Sirimanna P, Feldman LS, Darzi A, Aggarwal R. Systematic review of learning curves for minimally invasive abdominal surgery: a review of the methodology of data collection, depiction of outcomes, and statistical analysis. Ann Surg. 2014; 260: 37-45. doi: 10.1097/SLA.0000000000000596
  15. Kwak HY, Kim SH, Chae BJ. Song BJ, Jung SS, Bae JS. Learning curve for gasless endoscopic thyroidectomy using the trans-axillary approach: CUSUM analysis of a single surgeon’s experience. Int J Surg.. 2014 Dec;12(12):1273-7. doi: 10.1016/j.ijsu.2014.10.028
Address for correspondence:
625003, Russian Federation
Tyumen, Odessa st. 54
Tyumen State Medical University
Department of Faculty Surgery
e-mail: matveevia@mail.ru
Matveev Ivan A.
Information about the authors:
Matveev Ivan A., MD, Associate Professor, Head of the Department of Faculty Surgery, FSBEI HE “Tyumen State Medical University” of the Ministry of Health of Russia, Tyumen, Russian Federation.
http://orcid.org/0000-0003-1312-1971
Gibert Boris K., MD, Professor of the Department of Faculty Surgery, Tyumen State Medical University of the Ministry of Health of Russia; Head of the Surgical Service of GBUZ TO “Regional Clinical Hospital No. 1”, Tyumen, Russian Federation.
http://orcid.org/0000-0003-3947-9226
Aliev Fuad Shamil oglu, MD, Professor, Head of the Department of General Surgery, Tyumen State Medical University, Ministry of Health of Russia, Tyumen, Russian Federation.
Borodin Nikolay A., MD, Professor, Department of Faculty Surgery, Tyumen State Medical University, Ministry of Health of Russia, Tyumen, Russian Federation
Borodin Nikolay A., MD, Professor, Department of Faculty Surgery, Tyumen State Medical University, Ministry of Health of Russia, Tyumen, Russian Federation.
Matveev Anatoly I., PhD, Surgeon, GBUZ TO “Regional Clinical Hospital No. 1”. Tyumen, Russian Federation.
http://orcid.org/0000-0001-9213-4556
Morozova Lyudmila A. Chief Physician of NanoMed Plus LLC, Tyumen, Russian Federation.
orcid.org/0000-0003-3645-9916
Povarnin Nikolai N., Physician, Coloproctologist LLC “NanoMed Plus” Tyumen, Russian Federation.
http://orcid.org/0000-0003-4069-8071
Payusova Tatyana I., Associate Professor of the Department of Information Security, Institute of Mathematics and Computer Science, Tyumen State University, Tyumen, Russian Federation.

CASE REPORTS

K.F. CHERNOUSOV, R.V. KARPOVA, K.S. RUSSKOVA

PERCUTANEOUS MICROWAVE ABLATION OF A NON-PARASITIC SPLENIC CYST COMPLICATED BY PREVIOUS INTRACAVITAL BLEEDING. CASE REPORT

I.M. Sechenov First Moscow State Medical University, Moscow,
Russian Federation

Nonparasitic cysts of the spleen are a rare pathology. The need for their surgical treatment is due to the development of complications, including suppuration, hemorrhage into the cyst cavity and its rupture. A 28-year-old patient with a spleen cyst measuring 8x9x9 cm underwent repeated microwave ablation with prior drainage of the cavity with proteolytic enzymes. An obturation of residual cavity of the cyst occured, the postoperative period was uneventful. In case of previous hemorrhage into the cyst cavity, 24 hours before MVA, the cavity should be drained in order to lyse the blood clot using proteolytic enzyme preparations.

Keywords: splenic cyst, navigational surgery, percutaneous puncture, microwave ablation, case report
p. 65-70 of the original issue
References
  1. Pointer DT, Slakey DP. Cysts and Tumors of the Spleen [Internet]. Eighth Edi. Elsevier Inc.; 2019. Available from: doi: 10.1016/B978-0-323-40232-3.00142-4
  2. Chen YY, Shyr YM, Wang SE. Epidermoid Cyst of the Spleen. J Gastrointest Surg. 2013;17(3):555–61. doi: 10.1007/s11605-012-2088-y
  3. Samarakoon LB, Si Min Goh S, Cheong YL, Ong LY. Massive splenic epidermoid cyst in a child treated with laparoscopic partial splenectomy – case report and review of literature. Proc Singapore Healthc. 2019;28(1):61–4. doi: 10.1177/2010105818782523.
  4. Morgenstern L. Nonparasitic splenic cysts: Pathogenesis, classification, and treatment. J Am Coll Surg. 2002;194(3):306–14. doi: 10.1016/s1072-7515(01)01178-4.
  5. Karpova R, Gorbunov A, Mnatsakanyan M, Pogromov A, Sokolova I, Shumskaya Y, et al. Emergency splenectomy in a patient with splenic marginal zone lymphoma, acute portal vein thrombosis, and chronic viral hepatitis b. J Blood Med. 2021;12(1):431–4. doi: 10.1016/j.amsu.2019.03.014.
  6. Luo N, Wang Y, Geng Z, Qin X. Of feasibility, safety and effectiveness of ultrasound-guided percutaneous microwave ablation of splenic neoplasm. Oncol Lett. 2018;16(4):4807–12. doi: 10.3892/ol.2018.7845
  7. Karpova R, Mishin A, Guseinov S. Microwave ablation of splenic cyst: A case report. Ann Med Surg. 2019;41(March):40–2. doi: 10.1016/j.amsu.2019.03.014
  8. Morozov DA, Klyuev SA. Hyposlenism after splenectomy. Vestn Ross Akad Meditsinskikh Nauk. 2015;70(4):413–8. doi: 10.15690/vramn.v70.i4.1406
  9. Belyaeva AV., Rozinov VM, Polyaev YA, Belyaeva OA, Bondar ZM. Substantiation of organ-preserving surgical treatment of children with nonparasitic spleen cysts. Russ J Pediatr Surgery, Anesth Intensive Care. 2021;11(1):17–26. doi: 10.17816/psaic724
  10. Karfis EA, Roustanis E, Tsimoyiannis EC. Surgical management of nonparasitic splenic cysts. J Soc Laparoendosc Surg. 2009;13(2):207–12. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015942/pdf/jsls-13-2-207.pdf
  11. Stepanova YA, Alimurzaeva MZ, Ionkin DA. Ultrasonic differential diagnostics of cyst and cystic tumors of the spleen. Med Vis. 2020;24(3):63–75. doi: 10.24835/1607-0763-2020-3-63-75
  12. Akhan O, Dagoglu-Kartal MG, Ciftci T, Ozer C, Erbahceci A, Akinci D. Percutaneous Treatment of Non-parasitic Splenic Cysts: Long-Term Results for Single- Versus Multiple-Session Treatment. Cardiovasc Intervent Radiol. 2017;40(9):1421–30. doi: 10.1007/s00270-017-1650-0.
  13. Kenney CD, Hoeger YE, Yetasook AK, Linn JG, Denham EW, Carbray J, et al. Management of Non-Parasitic Splenic Cysts: Does Size Really Matter? J Gastrointest Surg. 2014;18(9):1658–63. doi: 10.1016/j.jss.2017.09.036
  14. Kondrashin SA, Kharnas SS, Musaev GK, Shiryaev ÀÀ. Combined interventional treatment of nonparasytic splenic cysts. Russ Electron J Radiol. 2011;1(1):33–9. URL: http://rejr.ru/volume/1/Kondrashin_article_1-1-2011.pdf
  15. Belyaeva OA, Kondrashin SA, Polyaev YA, et al. Combined navigating surgical interventions in children with solitary splenic cysts. Russ J Pediatr Surg. 2016;6(1):16–23. doi: 10.17816/psaic227
  16. Cairang Y, Zhang L, Ren B, Ren L, Hou L, Wang H, Zhou Y, Zhang Q, Shao J, Fan H. Efficacy and safety of ultrasound-guided percutaneous microwave ablation for the treatment of hepatic alveolar echinococcosis: A preliminary study. Medicine (Baltimore). 2017 Jul;96(27):e7137. doi: 10.1097/MD.0000000000007137
Address for correspondence:
119435, Russian Federation,
Moscow, Bolshaya Pirogovskaya str., 6-1,
I.M. Sechenov First Moscow State Medical University,
the Faculty Surgery Department No1,
tel.: +7 916 478-37-65,
e-mail: kirill_chernousov@bk.ru,
Kirill F. Chernousov
Information about the authors:
Karpova Radmila V., MD, Professor of the Faculty Surgery Department No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0003-0608-9846
Chernousov Kirill F., Post-Graduate Student, the Faculty Surgery Department No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0002-1751-4601
Russkova Ksenia S., Student, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
https://orcid.org/0000-0003-2150-7567

K.I. SERGATSKIY 1, 2, V.I. NIKOLSKY 1, M. ALJABR 1, I.V. MALYAKIN 2, E.O. SEMENOVA 1, A.A. SHANINA 1

CLINICAL OBSERVATIONS OF MALIGNANT TRANSFORMATION OF THE PILONIDAL CYST

Medical Institute FSEI HPE “Penza State University” 1,
SBHI “Penza Regional Clinical Hospital Named by. N.N. Burdenko” 2,
Russian Federation

Objective. To provide clinical examples of pilonidal cyst malignant transformation and to give recommendations on implementing oncological alertness in patients with long-term carriage of the epithelial coccygeal tract.
Methods. This publication describes two clinical cases of malignant transformation of the epithelial coccygeal tract. The surgical tactic consisted of a wide excision of formations within healthy tissues, together with fistulous openings and infiltratively changed soft tissues and skin over them in a single block up to the sacral fascia.
Results. Healing occurred by secondary intention. Histological examination showed «tumor-negative» resection margins, indicating an R0 resection was performed. The treatment carried out allowed for a satisfactory clinical result.
Discussion. Physicians should be aware of the possible malignant transformation of pilonidal disease, despite the rarity of this kind of complication.
Conclusion. Recommendations are given for implementing oncological alertness in patients with long-term carriage of pilonidal cysts.

Keywords: epithelial coccygeal passage, pilonidal disease, coccygeal cyst, pilonidal cancer, pilonidal carcinoma
p. 71-77 of the original issue
References
  1. Shelygin YuA. Clinical recommendations. Koloproktologiya. Moscow, RF: GEOTAR-Media; 2015. 528 ð. (In Russ.)
  2. Milone M, Velotti N, Manigrasso M, Milone F, Sosa Fernandez LM, De Palma GD. Video-assisted ablation of pilonidal sinus (VAAPS) versus sinusectomy for treatment of chronic pilonidal sinus disease: a comparative study. Updates Surg. 2019;71(1):179-83. doi: 10.1007/s13304-018-00611-2
  3. Pantyukov ED, Veliev TI, Shalyapin DI. Our experience of surgical treatment of epithelial coccygeal course. Koloproktologiya. 2018;(2S):28-28a. (In Russ.)
  4. Alptekin H, Yilmaz H, Kayis SA, Sahin M. Volume of the excised specimen and prediction of surgical site infection in pilonidal sinus procedures (surgical site infection after pilonidal sinus surgery). Surg Today. 2013;43(12):1365-70. doi: 10.1007/s00595-012-0444-x
  5. Mahmood F, Hussain A, Akingboye A. Pilonidal sinus disease: Review of current practice and prospects for endoscopic treatment. Ann Med Surg (Lond). 2020;57:212-17. doi: 10.1016/j.amsu.2020.07.050
  6. Shelygin YuA, Blagodarnyy LA. Spravochnik po Koloproktologii. Moscow, RF: Litterra: 2012. 606 p. (In Russ.)
  7. Dag A, Colak T, Turkmenoglu O, Sozutek A, Gundogdu R. Phenol procedure for pilonidal sinus disease and risk factors for treatment failure. Surgery. 2012 Jan;151(1):113-17. doi: 10.1016/j.surg.2011.07.015
  8. Khubezov DA, Lukanin RV, Krotkov AR, Ogoreltsev AYu, Serebryansky PV, Yudina EA. Results of laser obliteration in surgical treatment of epithelial coccygeal course. Koloproktologiya. 2020;19(2):91-103. doi: 10.33878/2073-7556-2020-19-2-91-103 (In Russ.)
  9. Zolotukhin DS, Sergiyko SV, Krochek IV. Modern methods of treatment of epithelial coccygeal stroke. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2021;24(1):80-88. doi: 10.37279/2070-8092-2021-24-1-80-88 (In Russ.)
  10. Lichman LA, Katorkin SE, Andreev PS, Davydova OE, Mikhaylichenko AP. Epithelial coccygeal cyst: a new approach to surgical treatment. Novosti Khirurgii. 2018;26(5):555-62. doi: 10.18484/2305-0047.2018.5.555 (In Russ.)
  11. Rivkin VL. Zabolevaniya pryamoy kishki. Moscow, RF: GEOTAR-Media; 2018. 128 p. (In Russ.)
  12. Dultsev YuV, Rivkin VL. Epitelial’nyy kopchikovyy khod. Moscow, RF: Medicine; 1988. 125 p. (In Russ.)
  13. Rivkin VL. Epithelial coccygeal course - a rudimentary remnant of the tail, the cause of sacrococcygeal suppuration. Nauka i Mir. 2015;(9-1):127-28. (In Russ.)
  14. Kober MM, Alapati U, Khachemoune A. Treatment options for pilonidal sinus. Cutis. 2018 Oct;102(4):E23-E29.
  15. Lurin IA, Tsema EV. Etiology and pathogenesis of pilonidal disease (literature review). Koloproktologiya. 2013;3(45):35-50. (In Russ.)
  16. Ryzhikh AN, Bitman MI. Epithelial passages of the coccygeal region as a cause of Suppurative Processes. Khirurgiya. 1949;(11):54-61. (In Russ.)
  17. Iesalnieks I, Deimel S, Schlitt HJ. “Pit picking” surgery for patients with pilonidal disease: mid-term results and risk factors. Chirurg. 2015;86(5):482-85. doi: 10.1007/s00104-014-2776-0
  18. Iesalnieks I, Deimel S, Schlitt HJ. “Pit picking” surgery for patients with pilonidal disease : mid-term results and risk factors. Chirurg. 2015 May;86(5):482-85. doi: 10.1007/s00104-014-2776-0 [Article in German]
  19. Michalopoulos N, Sapalidis K, Laskou S, Triantafyllou E, Raptou G, Kesisoglou I. Squamous cell carcinoma arising from chronic sacrococcygeal pilonidal disease: a case report. World J Surg Oncol. 2017 Mar 17;15(1):65. doi: 10.1186/s12957-017-1129-0
  20. Tsema YeV. Rak kopchikovoy kisty (obzor literatury). Onkolog Koloproktologiya. 201;(2):10-25. doi: 10.17650/2220-3478-2012-0-2-10-25
Address for correspondence:
440026, Russian Federation,
Penza, Lermontova Str., 3,
Penza State University,
Medical Institute,
Department of Surgery,
Tel. : 8 902 354-04-68,
e-mail: sergatsky@bk.ru
Sergatskiy Konstantin I.
Information about the authors:
Sergatskiy Konstantin Igorevich, MD, Associate Professor, Professor of Department of Surgery, Medical Institute of FSBEE HE «Penza State University». Coloproctologist Department of Coloproctology SBME «Penza Regional Clinical Hospital named after N.N. Burdenko», Penza, Russian Federation.
https://orcid.org/0000-0002-3334-8244
Nikolsky Valery Isaakovich, MD, Professor, Professor of Department of Surgery, Medical Institute of FSBEE HE «Penza State University», Russia, Penza, Lermontova.
https://orcid.org/0000-0002-9927-580X
Mîkhammad Aljabr, Assistant of the Department of Surgery, Medical Institute, Penza State University, Penza, Russian Federation,
https://orcid.org/0000-0003-3545-3707
Malyakin Ivan V., Coloproctologist, Department of Coloproctology, Penza Regional Clinical Hospital. N.N. Burdenko”, Penza, Russian Federation.
https://orcid.org/0000-0003-2249-4382
Semenova Ekaterina Olegovna, 5th year Student of the Medical Institute of the Penza State University, Penza, Russian Federation.
http://orcid.org/0000-0003-2374-8241
Shanina Angelina Alexandrovna, 5th Year Student of the Medical Institute of Penza State University, Penza, Russian Federation.
https://orcid.org/0000-0003-3722-9370

ANNIVERSARIES

THE 50TH ANNIVERSARY OF ALEXEY EVGENIEVICH SHCHERBA

À.Å.ÙåðáàOn May 9, 2023, Aleksey Evgenievich Shcherba, one of the leading surgeons of the Republic of Belarus, Doctor of Medical Sciences, Professor, Deputy Director for Surgery of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology" celebrated his 50th anniversary.
A.E. Shcherba was born in Minsk in the family of doctors.
After finishing the secondary school No. 54 in Minsk, he entered Minsk State Medical Institute, from which he graduated with honors in 1996 and was referred to the clinical residency at the department of surgical diseases No. 2 of Minsk State Medical Institute on a specialty “Surgery”.

After training in residency A.E. Shcherba started work as a surgeon at the emergency surgery department of the City Clinical Hospital No. 9 in Minsk. In 2006, without interrupting his practical activities, he defended his Ph.D. thesis on the topic: “Peculiarities of local treatment of necrotizing parapancreatitis” in the specialty 14.01.17 - “surgery” (under the supervision of Academician of the National Academy of Sciences, Prof. S.I. Tretyak).
The time of advancing of A.E. Shcherba as a practical surgeon and scientist coincided with the beginning of a new medical field development in our country - clinical transplantology. A.E. Shcherba became one of the main protagonists of a young team of like-minded enthusiasts, who were gathered by a new Head of the surgical service of the City Clinical Hospital No. 9 in Minsk, and now the director of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology" acad. NAS, prof. O.O. Rummo.
A.E. Shcherba was in the team of specialists who performed the country's first liver transplant on April 2, 2008, and the second operation - on April 13. Great merit of Aleksey Evgenievich is that this operation from a unique one subsequently became accessible. He was entrusted to supervise the liver transplantation program and its development in the transplantology department founded in 2010 in the Republican Scientific and Practical Center "Transplantation of Organs and Tissues" on the basis of the 9th City Clinical Hospital, Minsk.
This activity helped to reveal fully the natural gift of A.E. Shcherba - surgical practice full of quests, based on enormous diligence and the broadest medical erudition, natural curiosity and the desire to “get to the very essence” in everything. Since that time Alexei Evgenievich has performed hundreds of operations; not only residents of our republic, but also patients from all countries of the former Soviet Union and many foreign countries began to turn to him for a consultation. At present, A.E. Shcherba is a recognized authority in the diagnosis and treatment of the liver and pancreas diseases, transplant surgery, oncology and immunosuppression not only in our republic, but also far beyond its borders. A special merit of A.E. Shcherba was the program of the pediatric liver transplantation, successfully implemented in our country.
As a team member of Belarusian specialists, Aleksey Evgenievich took an active part in the development of national programs for liver transplantation in adults and children in the fraternal republics - the Republics of Kazakhstan and Armenia, he selected, planned and performed operations in foreign patients, including patients from the countries with a highly developed medicine, such as Israel, Japan, USA, UAE. Also, the successful liver transplantation performed by the team of specialists led by O.O. Rummo to Israel statesman M. Dogan, in which A.E. Shcherba took an active part gained much international attention.
An incomplete list of scientific interests of A.E. Shcherba and his practical achievements are striking in their vastness: the development and implementation in clinical practice of modern surgical technologies for the treatment of patients with severe lesions of the liver, pancreas, liver transplantation, the use of cellular technologies, optimization of immunosuppression, the principles of selecting a recipient and allocating a donor organ, transplantation oncology, liver surgery and the principles of vascular isolation and blood saving, the principles of biliary reconstruction, liver pathology during pregnancy and trauma, the use of vascular allografts in hepatopancreatic surgery, portal hypertension syndrome.
In 2018, without discontinuing his practical work, A.E. Shcherba successfully defended his doctoral dissertation on the topic: "Prediction and complex treatment of postoperative dysfunction of the liver transplants" in the specialty 14.01.24 - "transplantation and artificial organs" (supervisor - Academician of the National Academy of Sciences, Prof. Rummo O.O.), and in 2023 he was awarded the title of professor.
It should be noted that the scientific activity of Alexei Evgenievich is marked by the desire for a deep pathophysiological elaboration of the studied problem. This allows the author to make highly reasoned conclusions and recommendations. And in daily practice, encyclopedic knowledge, experience and critical thinking allow him to use the same pathophysiological approach to choosing a treatment strategy and tactics for each patient, to logically justify his decisions during rounds, numerous consultations and discussions with colleagues.
Since 2018 up to the present, Shcherba A.E. has been Head of the surgical service of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology" as deputy director for surgical work.
One Ph.D thesis has been defended under the supervision of A.E. Shcherba. The results of his scientific research are shown in more than 300 publications. He is the author and co-author of 10 patents of the Republic of Belarus and 1 Eurasian patent. Alexey Evgenievich has been actively teaching since the beginning of the organization of the department of transplantology of BelMAPO, since 2010 - as associate professor, and since 2018 as Professor of the department.
Achievements of A.E. Shcherba were marked bya number of government awards of the Republic of Belarus - for the work "Development and implementation of organ transplantation technologies in children and adults" in 2016 A.E. Shcherba, together with co-authors, was awarded the State Prize of the Republic of Belarus.
Alexei Evgenievich was awarded the title of "Excellent Health Worker of the Republic of Belarus", he was awarded the diploma of Minsk City Executive Committee, the medal of the Belarusian Orthodox Church of St. Euphrosyne of Polotsk, a badge "For Contribution to the Development of Healthcare in Kazakhstan".
In addition to the professional and scientific accomplishments A.E. Shcherba enjoys great respect and love not only among the staff of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology", but also among all his colleagues - for his readiness to help immediately, take responsibility, for his innate tact, goodwill and respect in relation to subordinates, and to everyone who has ever addressed him.
Alexei Evgenievich meets his 50th birthday in the prime of his creative powers, full of energy and new ideas among like-minded people dedicated to the common goal.
The staff of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology" is convinced that, despite all the achievements, Alexei Evgenievich is just entering the period of his creative rise. “The main matches have not been played...”, as Eduard Khil once sang.
The staff of the State Institution "Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology" heartily congratulates Alexei Evgenievich on his anniversary, wishes him health, creative success and well-being!

p. 78-79 of the original issue
Contacts | ©Vitebsk State Medical University, 2007-2023